These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20360582)

  • 1. Lack of clear statement and outrage from ASHP on Cropp case.
    Poikonen J
    Am J Health Syst Pharm; 2010 Apr; 67(8):602-3; author reply 603. PubMed ID: 20360582
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 3. Leadership obligations and the ASHP national surveys.
    Weber RJ
    Am J Health Syst Pharm; 2015 Jul; 72(13):1095. PubMed ID: 26092959
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP policy recommendations--invitation to comment.
    American Society of Hospital Pharmacists
    Am J Health Syst Pharm; 2003 Apr; 60(7):701-4. PubMed ID: 12701555
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.
    Meyer GE; Keith TD; Gutfeld MB; Johnson D
    Am J Hosp Pharm; 1994 Feb; 51(4):520-1. PubMed ID: 8017422
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP statement on the health-system pharmacist's role in national health care quality initiatives.
    Am J Health Syst Pharm; 2010 Apr; 67(7):578-9. PubMed ID: 20237388
    [No Abstract]   [Full Text] [Related]  

  • 7. APhA federal pharmacy initiatives: supporting those in harm's way.
    Tackitt RD
    J Am Pharm Assoc (2003); 2007; 47(5):566. PubMed ID: 17848341
    [No Abstract]   [Full Text] [Related]  

  • 8. Women pharmacists in hospital and community practice.
    Kirk KW; Ohvall RA
    Am J Hosp Pharm; 1972 Sep; 29(9):761-6. PubMed ID: 4637452
    [No Abstract]   [Full Text] [Related]  

  • 9. APhA2009 House of Delegates: serving the association and the profession.
    Weitzel KW; Tisdale JE; Mattingly J
    J Am Pharm Assoc (2003); 2009; 49(4):474-80. PubMed ID: 19589755
    [No Abstract]   [Full Text] [Related]  

  • 10. American pharmacy--a retrospective future.
    Sonnedecker G
    J Am Pharm Assoc; 1973 Mar; 13(3):128-30 passim. PubMed ID: 4689932
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP statement on reporting medical errors.
    Am J Health Syst Pharm; 2000 Aug; 57(16):1531-2. PubMed ID: 10965397
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP statement on the hospital pharmacist's role in infection control.
    Am J Hosp Pharm; 1978 Jul; 35(7):814-5. PubMed ID: 665702
    [No Abstract]   [Full Text] [Related]  

  • 13. ASHP, politics, and reimbursement.
    Riddiough MA
    Am J Hosp Pharm; 1979 Feb; 36(2):154, 161. PubMed ID: 420201
    [No Abstract]   [Full Text] [Related]  

  • 14. ASHP statement on clinical functions in institutional pharmacy practice.
    Am J Hosp Pharm; 1978 Jul; 35(7):813. PubMed ID: 665700
    [No Abstract]   [Full Text] [Related]  

  • 15. An ASHP training program for Army pharmacists.
    Watkins LT
    Am J Health Syst Pharm; 2003 Mar; 60(6):547. PubMed ID: 12659054
    [No Abstract]   [Full Text] [Related]  

  • 16. ASHP policy recommendations--invitation to comment.
    Am J Health Syst Pharm; 2001 Apr; 58(7):603-6. PubMed ID: 11296611
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 18. Technology-enabled practice: a vision statement by the ASHP Section of Pharmacy Informatics and Technology.
    ASHP Section of Pharmacy Informatics and Technology Executive Committee, 2008-09
    Am J Health Syst Pharm; 2009 Sep; 66(17):1573-7. PubMed ID: 19710443
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP statement on third-party compensation for clinical services by pharmacists.
    Am J Hosp Pharm; 1985 Jul; 42(7):1580-1. PubMed ID: 4025361
    [No Abstract]   [Full Text] [Related]  

  • 20. Grassroots lobbying: an important tool for pharmacy. Developing grassroots advocate.
    Boyle C
    J Am Pharm Assoc (2003); 2004; 44(1):5-6. PubMed ID: 14965144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.